Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15067853 | 0.89 | USP2 (0.35) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL5050251 | 0.86 | USP2 (0.33) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL11686432 | 0.79 | ALDH1A1 (0.46) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL4256624 | 0.76 | TSHR (0.31) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL16167050 | 0.74 | — | — | |
| SCHEMBL28173687 | 0.74 | ABCB11 (0.39) | — | |
| SCHEMBL2695258 | 0.74 | ALDH1A1 (0.42) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL184762 | 0.73 | TSHR (0.41) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL4456298 | 0.73 | USP2 (0.31) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL7790218 | 0.72 | ALDH1A1 (0.42) | ALDH1A1USP2GAAPKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-04 | — | — | US | claimed |
| WO-2023196594-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-12 | — | — | WO | claimed |
| EP-3908566-B1 | PREPARATION OF 5-ARYL PENTANOLS | BASF SE (DE) | 2023-07-26 | — | — | EP | claimed |
| CN-115385957-A | Linear terphenyl aryl phosphine ligand and transition metal complex thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115385955-A | Tetrabiarylphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115385956-A | Biaryl diphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| US-11365168-B2 | Preparation of 5-aryl-pentanols | BASF SE (DE) | 2022-06-21 | — | — | US | claimed |
| CN-113260603-A | Preparation of 5-arylpentanols | 巴斯夫欧洲公司 | 2021-08-13 | — | — | CN | claimed |
| CN-111978953-A | Long-afterglow luminescent composition based on BODIPY luminophor and application | 复旦大学 | 2020-11-24 | — | — | CN | claimed |
| US-8344142-B2 | perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| US-8039625-B2 | Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-18 | — | — | US | claimed |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2009-02-19 | — | — | US | claimed |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2008-09-18 | — | — | US | claimed |
| WO-2006093965-A2 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-09-08 | — | — | WO | claimed |
| US-20060142159-A1 | Plant-protective agents in the form of suspensions | MEYER GERD R | 2006-06-29 | — | — | US | claimed |
| WO-2005124453-A2 | PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| US-20050182219-A1 | Crystallization inhibitor for plant-protective formulations | MEYER GERD R (DE) | 2005-08-18 | — | — | US | claimed |
| US-20050148709-A1 | Solid plant-protective formulations | CLARIANT GMBH (DE) | 2005-07-07 | — | — | US | claimed |
| WO-2005054370-A2 | ANTIFOAMING AGENT | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2005-06-16 | — | — | WO | claimed |
| US-20050085391-A1 | Aqueous plant-protection formulations | MEYER GERD R (DE) | 2005-04-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | ALDH1A1 4484/4885USP2 4831/4885GAA 1861/4885 |
| US-11365168-B2 | Preparation of 5-aryl-pentanols | HPD, CYP3A5, HTR3C | ALDH1A1 127/4885USP2 1492/4885GAA 2815/4885 |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | SLC43A1, SLC3A2, SLC16A3 | ALDH1A1 1563/4885USP2 3600/4885GAA 2697/4885 |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | SLC18A3, CORO1C, SLC18A1 | ALDH1A1 2790/4885USP2 2321/4885GAA 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.